Article
The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues
15 Sept 2020
Abstract excerpt
BACKGROUND: Hepatocellular carcinoma (HCC) remains one of the most common cancers worldwide and tends to be detected at an advanced stage. More effective biomarkers for HCC screening and prognosis assessment are needed and the mechanisms of HCC require further exploration. The role of MAOA in HCC has not been intensively investigated. METHODS: In-house tissue microarrays, genechips, and RNAsequencing datasets...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
